Induced pluripotent cancer cells: Progress and application

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 1, 2011, Pages 1-8

  Sun, Chun ^a,b   Liu, Yin Kun ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Cancer stem cell; Induced pluripotent cancer cell; Induced pluripotent stem cell; Oncogenesis; Reprogramming; Transcription factor

Indexed keywords

KRUPPEL LIKE FACTOR 4; MICRORNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; WNT3A PROTEIN;

ARTICLE; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL RENEWAL; EMBRYONIC STEM CELL; EPIGENETICS; GENE OVEREXPRESSION; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TERATOMA;

ANIMALS; CELL LINE, TUMOR; EMBRYONIC STEM CELLS; EPIGENOMICS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEOPLASMS; NUCLEAR REPROGRAMMING; TRANSCRIPTION FACTORS;

EID: 78751635807     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0955-z     Document Type: Article

References (62)

1. Y Atlasi SJ Mowla SA Ziaee AR Bahrami 2007 OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer Int J Cancer 120 7 1598 1602 1:CAS:528:DC%2BD2sXis12itr4%3D 10.1002/ijc.22508 17205510 (Pubitemid 46355399)
2. KM Bae Z Su C Frye S McClellan RW Allan JT Andrejewski V Kelley M Jorgensen DA Steindler J Vieweg DW Siemann 2010 Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells J Urol 183 5 2045 2053 1:CAS:528:DC%2BC3cXlvFOmsbs%3D 10.1016/j.juro.2009.12.092 20303530
3. RH Blelloch K Hochedlinger Y Yamada C Brennan M Kim B Mintz L Chin R Jaenisch 2004 Nuclear cloning of embryonal carcinoma cells Proc Natl Acad Sci USA 101 39 13985 13990 1:CAS:528:DC%2BD2cXosVymu7c%3D 15306687
4. C Boltze S Zack C Quednow S Bettge A Roessner R Schneider-Stock 2003 Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis Pathol ResPract 199 6 399 404 1:CAS:528:DC%2BD3sXot1SjtbY%3D 10.1078/0344-0338-00436 (Pubitemid 36974825)
5. S Bomken K Fiser O Heidenreich J Vormoor 2010 Understanding the cancer stem cell Brit J cancer 103 4 439 445 1:CAS:528:DC%2BC3cXhtVSmtb7M 10.1038/sj.bjc.6605821 20664590
6. JE Carette J Pruszak M Varadarajan VA Blomen S Gokhale FD Camargo M Wernig R Jaenisch TR Brummelkamp 2010 Generation of iPSCs from cultured human malignant cells Blood 115 20 4039 4042 1:CAS:528:DC%2BC3cXnt1Ggsb8%3D 20233975
7. G Chang YL Miao Y Zhang S Liu Z Kou J Ding DY Chen QY Sun S Gao 2010 Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells PLoS One 5 4 e10320 10.1371/journal.pone.0010320 20436676
8. RZ Chen U Pettersson C Beard L Jackson-Grusby R Jaenisch 1998 DNA hypomethylation leads to elevated mutation rates Nature 395 6697 89 93 1:CAS:528:DyaK1cXmtVWjsr8%3D 10.1038/25779 9738504 (Pubitemid 28420236)
9. A Eden F Gaudet A Waghmare R Jaenisch 2003 Chromosomal instability tumors promoted by DNA hypomethylation Science 300 5618 455 1:CAS:528: DC%2BD3sXktlektb8%3D 10.1126/science.1083557 12702868 (Pubitemid 36444319)
10. S Eminli A Foudi M Stadtfeld N Maherali T Ahfeldt G Mostoslavsky H Hock K Hochedlinger 2009 Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells Nat Genet 41 9 968 976 1:CAS:528:DC%2BD1MXps1aht70%3D 10.1038/ng.428 19668214
11. AP Feinberg 1999 Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction Cancer Res 59 7 Suppl 1743s 1746s 1:CAS:528:DyaK1MXisVWrs7s%3D 10197590
12. AP Feinberg B Vogelstein 1983 Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 5895 89 92 1:CAS:528:DyaL3sXms1ertA%3D%3D 10.1038/301089a0 6185846 (Pubitemid 13154475)
13. AR Florl R Lower BJ Schmitz-Drager WA Schulz 1999 DNA methylation and expression of LINE-1 and HERV-k provirus sequences in urothelial and renal cell carcinomas Br J Cancer 80 9 1312 1321 1:CAS:528:DyaK1MXltVWltLw%3D 10.1038/sj.bjc.6690524 10424731 (Pubitemid 29308598)
14. KW Foster AR Frost P McKie-Bell CY Lin JA Engler WE Grizzle JM Ruppert 2000 Increase of GKLF messenger RNA and protein expression during progression of breast cancer Cancer Res 60 22 6488 6495 1:CAS:528:DC%2BD3cXos1Sktbw%3D 11103818
15. KW Foster Z Liu CD Nail X Li TJ Fitzgerald SK Bailey AR Frost ID Louro TM Townes AJ Paterson JE Kudlow SM Lobo-Ruppert JM Ruppert 2005 Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia Oncogene 24 9 1491 1500 1:CAS:528:DC%2BD2MXhsFOqsL0%3D 10.1038/sj.onc.1208307 15674344 (Pubitemid 40396079)
16. Gardner L, Lee L, Dang C (2002) The c-Myc oncogenic transcription factor. In: The encyclopedia of cancer, 2nd edn. Academic Press
17. F Gaudet JG Hodgson A Eden L Jackson-Grusby J Dausman JW Gray H Leonhardt R Jaenisch 2003 Induction of tumors in mice by genomic hypomethylation Science 300 5618 489 492 1:CAS:528:DC%2BD3sXivFyms7Y%3D 10.1126/science.1083558 12702876 (Pubitemid 36444330)
18. WC Gustafson WA Weiss 2010 Myc proteins as therapeutic targets Oncogene 29 9 1249 1259 1:CAS:528:DC%2BC3cXis1yltr0%3D 10.1038/onc.2009.512 20101214
19. J Hanna K Saha B Pando J van Zon CJ Lengner MP Creyghton A van Oudenaarden R Jaenisch 2009 Direct cell reprogramming is a stochastic process amenable to acceleration Nature 462 7273 595 601 1:CAS:528:DC%2BD1MXhtlOrurjN 10.1038/nature08592 19898493
20. AH Hart L Hartley K Parker M Ibrahim LH Looijenga M Pauchnik CW Chow L Robb 2005 The pluripotency homeobox gene NANOG is expressed in human germ cell tumors Cancer 104 10 2092 2098 1:CAS:528:DC%2BD2MXht1Clu7fI 10.1002/cncr.21435 16206293 (Pubitemid 41579954)
21. YC Henderson Y Chen MJ Frederick SY Lai GL Clayman 2010 MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo Mol Cancer Ther 9 7 1968 1976 1:CAS:528:DC%2BC3cXhtFertbnE 10.1158/1535-7163.MCT-10-0062 20587665
22. CE Hoei-Hansen K Almstrup JE Nielsen S Brask Sonne N Graem NE Skakkebaek H Leffers E Rajpert-De Meyts 2005 Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours Histopathology 47 1 48 56 1:STN:280:DC%2BD2Mzjt1Shug%3D%3D 10.1111/j.1365-2559.2005.02182.x 15982323 (Pubitemid 40978813)
23. H Hong K Takahashi T Ichisaka T Aoi O Kanagawa M Nakagawa K Okita S Yamanaka 2009 Suppression of induced pluripotent stem cell generation by the p53-p21 pathway Nature 460 7259 1132 1135 1:CAS:528:DC%2BD1MXps1ahsbc%3D 10.1038/nature08235 19668191
24. T Hu S Liu DR Breiter F Wang Y Tang S Sun 2008 Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis Cancer Res 68 16 6533 6540 1:CAS:528:DC%2BD1cXpslKnur4%3D 10.1158/0008-5472.CAN-07-6642 18701476
25. D Huangfu R Maehr W Guo A Eijkelenboom M Snitow AE Chen DA Melton 2008 Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds Nat Biotechnol 26 7 795 797 1:CAS:528: DC%2BD1cXot1entL0%3D 10.1038/nbt1418 18568017 (Pubitemid 351961456)
26. D Huangfu K Osafune R Maehr W Guo A Eijkelenboom S Chen W Muhlestein DA Melton 2008 Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 Nat Biotechnol 26 11 1269 1275 1:CAS:528: DC%2BD1cXhtlCktrvE 10.1038/nbt.1502 18849973
27. JM Irish N Kotecha GP Nolan 2006 Mapping normal and cancer cell signalling networks towards single-cell proteomics Nat Rev Cancer 6 2 146 155 1:CAS:528:DC%2BD28Xht1els7g%3D 10.1038/nrc1804 16491074 (Pubitemid 43361547)
28. RL Judson JE Babiarz M Venere R Blelloch 2009 Embryonic stem cell specific microRNAs promote induced pluripotency Nat Biotechnol 27 5 459 461 1:CAS:528:DC%2BD1MXksVekt78%3D 10.1038/nbt.1535 19363475
29. C Lengauer 2003 Cancer: an unstable liaison Science 300 5618 442 443 1:CAS:528:DC%2BD3sXktlekt7s%3D 10.1126/science.1084468 12702865 (Pubitemid 36444316)
30. Li H, Collado M, Villasante A, Strati K, Ortega S, Cañamero M, Blasco MA, Serrano M (2009a) The ink/arf locus is a barrier for ips cell reprogramming. Nature 460(7259):1136-1139
31. W Li W Wei S Zhu J Zhu Y Shi T Lin E Hao A Hayek H Deng S Ding 2009 Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors Cell Stem Cell 4 1 16 19 10.1016/j.stem.2008.11.014 19097958
32. Q Lian Y Zhang J Zhang HK Zhang X Wu Y Zhang FF Lam S Kang JC Xia WH Lai KW Au YY Chow CW Siu CN Lee HF Tse 2010 Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice Circulation 121 9 1113 1123 10.1161/CIRCULATIONAHA.109.898312 20176987
33. SL Lin DC Chang S Chang-Lin CH Lin DT Wu DT Chen SY Ying 2008 Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state RNA 14 10 2115 2124 1:CAS:528:DC%2BD1cXht1ektLfK 10.1261/rna.1162708 18755840
34. D Liu M Xing 2008 Potent inhibition of thyroid cancer cells by the MEK inhibitor PD0325901 and its potentiation by suppression of the PI3 K and NF-kappaB pathways Thyroid 18 8 853 864 10.1089/thy.2007.0357 18651802
35. SK Mallanna A Rizzino 2010 Emerging roles of microRNAs in the control of embryonic stem cells and the generation of iPS cells Dev Biol 344 1 16 25 1:CAS:528:DC%2BC3cXhtVClurfN 10.1016/j.ydbio.2010.05.014 20478297
36. A Marson R Foreman B Chevalier S Bilodeau M Kahn RA Young R Jaenisch 2008 Wnt signaling promotes reprogramming of somatic cells to pluripotency Cell Stem Cell 3 2 132 135 1:CAS:528:DC%2BD1cXhtVegtr7N 10.1016/j.stem.2008.06.019 18682236
37. A Merlo JG Herman L Mao DJ Lee E Gabrielson PC Burger SB Baylin D Sidransky 1995 5′CpG island methylation is associated with transcription silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 7 686 692 1:CAS:528:DyaK2MXms1Kgtr4%3D 10.1038/nm0795-686 7585152
38. TS Mikkelsen J Hanna X Zhang M Ku M Wernig P Schorderet BE Bernstein R Jaenisch ES Lander A Meissner 2008 Dissecting direct reprogramming through integrative genomic analysis Nature 454 7200 49 55 1:CAS:528: DC%2BD1cXotVertb4%3D 10.1038/nature07056 18509334 (Pubitemid 351931978)
39. M Mimeault SK Batra 2008 Recent progress on tissue-resident adult stem cell biology and their therapeutic implications Stem Cell Rev 4 1 27 49 10.1007/s12015-008-9008-2 18288619
40. N Miyoshi H Ishii K Nagai H Hoshino K Mimori F Tanaka H Nagano M Sekimoto Y Doki M Mori 2010 Defined factors induce reprogramming of gastrointestinal cancer cells Proc Natl Acad Sci U S A 107 1 40 45 1:CAS:528: DC%2BC3cXnsFCgsA%3D%3D 10.1073/pnas.0912407107 20018687
41. K Nagai H Ishii N Miyoshi H Hoshino T Saito T Sato Y Tomimaru S Kobayashi H Nagano M Sekimoto Y Doki M Mori 2010 Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells Biochem Biophys Res Commun 395 2 258 263 1:CAS:528:DC%2BC3cXlsFGgtLo%3D 10.1016/j.bbrc.2010.03.176 20381452
42. T Nishii M Yashiro O Shinto T Sawada M Ohira K Hirakawa 2009 Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma Cancer Sci 100 8 1397 1402 1:CAS:528:DC%2BD1MXhtVWnsLrI 10.1111/j.1349-7006.2009.01211.x 19493275
43. JH Phi SH Park SK Kim SH Paek JH Kim YJ Lee BK Cho CK Park DH Lee KC Wang 2008 Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway Am J Surg Pathol 32 1 103 112 10.1097/PAS. 0b013e31812f6ba6 18162777
44. A Raya I Rodríguez-Pizà G Guenechea R Vassena S Navarro MJ Barrero A Consiglio M Castellà P Río E Sleep F González G Tiscornia E Garreta T Aasen A Veiga IM Verma J Surrallés J Bueren JC Izpisúa Belmonte 2009 Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells Nature 460 7251 53 59 1:CAS:528:DC%2BD1MXms1aktLo%3D 10.1038/nature08129 19483674
45. T Reya SJ Morrison MF Clarke IL Weissman 2001 Stem cells, cancer, and cancer stem cells Nature 414 6859 105 111 1:CAS:528:DC%2BD3MXot1ahs7c%3D 10.1038/35102167 11689955 (Pubitemid 33041634)
46. SM Rodriguez-Pinilla D Sarrio G Moreno-Bueno Y Rodriguez-Gil MA Martinez L Hernandez D Hardisson JS Reis-Filho J Palacios 2007 Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer Mod Pathol 20 4 474 481 1:CAS:528:DC%2BD2sXjtlylt7g%3D 10.1038/modpathol.3800760 17334350 (Pubitemid 46482371)
47. Y Sanada K Yoshida M Ohara M Oeda K Konishi Y Tsutani 2006 Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components Pancreas 32 2 164 170 1:CAS:528: DC%2BD28XivVCqtbY%3D 10.1097/01.mpa.0000202947.80117.a0 16552336
48. S Santagata JL Hornick KL Ligon 2006 Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOG Am J Surg Pathol 30 12 1613 1618 10.1097/01.pas.0000213320.04919.1a 17122519 (Pubitemid 44808799)
49. U Schagdarsurengin O Gimm C Hoang-Vu H Dralle GP Pfeifer R Dammann 2002 Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma Cancer Res 62 12 3698 3701 1:CAS:528:DC%2BD38XltF2jtb4%3D 12097277
50. M Schoenhals A Kassambara J De Vos D Hose J Moreaux B Klein 2009 Embryonic stem cell markers expression in cancers Biochem Biophys Res Commun 383 2 157 162 1:CAS:528:DC%2BD1MXltFWntbs%3D 10.1016/j.bbrc.2009.02.156 19268426
51. Y Shi JT Do C Desponts HS Hahm HR Schöler S Ding 2008 A combined chemical and genetic approach for the generation of induced pluripotent stem cells Cell Stem Cell 2 6 525 528 1:CAS:528:DC%2BD1cXntFalsLo%3D 10.1016/j.stem.2008.05.011 18522845 (Pubitemid 351729222)
52. Y Shi C Desponts JT Do HS Hahm HR Schöler S Ding 2008 Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and klf with small-molecular compounds Cell Stem Cell 3 5 568 574 1:CAS:528: DC%2BD1cXhsVaqs7%2FJ 10.1016/j.stem.2008.10.004 18983970
53. J Silva O Barrandon J Nichols J Kawaguchi TW Theunissen A Smith 2008 Promotion of reprogramming to ground state pluripotency by signal inhibition PLoS Biol 6 10 e253 10.1371/journal.pbio.0060253 18942890
54. K Takahashi S Yamanaka 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 4 663 676 1:CAS:528:DC%2BD28Xpt1aktbs%3D 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
55. JA Tsou JA Hagen CL Carpenter IA Laird-Offringa 2002 DNA methylation analysis: a powerful new tool for lung cancer diagnosis Oncogene 21 35 5450 5461 1:CAS:528:DC%2BD38XlslSqt7g%3D 10.1038/sj.onc.1205605 12154407 (Pubitemid 34983481)
56. J Utikal JM Polo M Stadtfeld N Maherali W Kulalert RM Walsh A Khalil JG Rheinwald K Hochedlinger 2009 Immortalization eliminates a roadblock during cellular reprogramming into iPS cells Nature 460 7259 1145 1148 1:CAS:528:DC%2BD1MXps1ags78%3D 10.1038/nature08285 19668190
57. J Utikal N Maherali W Kulalert K Hochedlinger 2009 Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells J Cell Sci 122 Pt 19 3502 3510 1:CAS:528:DC%2BD1MXhsVSkurnK 10.1242/jcs.054783 19723802
58. MH Wright AM Calcagno CD Salcido MD Carlson SV Ambudkar L Varticovski 2008 Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics Breast Cancer Res 10 1 R10 10.1186/bcr1855 18241344
59. M Xing Y Cohen E Mambo G Tallini R Udelsman PW Ladenson D Sidransky 2004 Early ocurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis Cancer Res 64 5 1664 1668 1:CAS:528: DC%2BD2cXhslekur4%3D 10.1158/0008-5472.CAN-03-3242 14996725 (Pubitemid 38428687)
60. S Yamanaka 2009 Elite and stochastic models for induced pluripotent stem cell generation Nature 460 7251 49 52 1:CAS:528:DC%2BD1MXotVSgu7c%3D 10.1038/nature08180 19571877
61. F Ye C Zhou Q Cheng J Shen H Chen 2008 Stem-cell-abundant proteins nanog, nucleostemin and musashi1 are highly expressed in malignant cervical epithelial cells BMC Cancer 8 108 10.1186/1471-2407-8-108 18419830 (Pubitemid 351715994)
62. XY Zhao W Li Z Lv L Liu M Tong T Hai J Hao CL Guo QW Ma L Wang F Zeng Q Zhou 2009 iPS cells produce viable mice through tetraploid complementation Nature 461 7260 86 90 1:CAS:528:DC%2BD1MXhtVygsLfF 10.1038/nature08267 19672241